James Healy

Insider Reports History

Entity
Individual
Location
3000 Sand Hill Road, 4 250, Menlo Park, California
Signature
/s/ Tami Chen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Healy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Natera, Inc. Director Common Stock 1.55M $158M $102.18 Jul 26, 2024 by Sofinnova Venture Partners IX, L.P.
Y-mAbs Therapeutics, Inc. Director Common Stock 2.19M $26.3M $12.00 Jun 11, 2024 Indirect
Natera, Inc. Director Common Stock 45.9K $4.69M $102.18 Jul 26, 2024 Direct
Y-mAbs Therapeutics, Inc. Director Common Stock 31.6K $379K $12.00 Jun 11, 2024 Direct
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 Mar 18, 2024 By Sofinnova Management X, L.P.
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 Mar 18, 2024 By Sofinnova Synergy Master Fund, LP
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 Mar 18, 2024 By Sofinnova Venture Partners X, LP
Karuna Therapeutics, Inc. Director Common Stock 0 $0 $330.00 Mar 18, 2024 Direct
Karuna Therapeutics, Inc. Director Option (right to buy) 0 $0 $92.30 Mar 18, 2024 Direct
Rapport Therapeutics, Inc. Director Common Stock 1.86M Jul 1, 2024 By Sofinnova Venture Partners XI, L.P.
ArriVent Biopharma, Inc. Director Common Stock 1.7M Jan 30, 2024 Sofinnova Venture Partners XI, L.P.
Rapport Therapeutics, Inc. Director Common Stock 40.9K Jul 1, 2024 By Crestline Summit Master, SPC - PEAK SP
Rapport Therapeutics, Inc. Director Common Stock 39.7K Jul 1, 2024 By CRESTLINE SUMMIT PINNACLE MASTER, L.P.
Rapport Therapeutics, Inc. Director Common Stock 33.1K Jul 1, 2024 By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP
Coherus BioSciences, Inc. Director Stock Option (Right to Buy) 27K Jan 7, 2022 Direct
Bolt Biotherapeutics, Inc. Director Stock Option (Right to Buy) 22K Jun 12, 2024 Direct
Rapport Therapeutics, Inc. Director Common Stock 18.6K Jul 1, 2024 By Sofinnova Synergy Master Fund LP
Y-mAbs Therapeutics, Inc. Director Employee Stock Option (right to buy) 14.5K Jun 11, 2024 Direct
ArriVent Biopharma, Inc. Director Series B Preferred Stock 0 Jan 30, 2024 Sofinnova Venture Partners XI, L.P.
CinCor Pharma, Inc. Director, 10%+ Owner Common Stock 0 $28.75 Nov 28, 2022 By Sofinnova Synergy Master Fund, LP
CinCor Pharma, Inc. Director, 10%+ Owner Common Stock 0 $28.75 Feb 24, 2023 By Sofinnova Venture Partners X, L.P.
CinCor Pharma, Inc. Director, 10%+ Owner Common Stock 0 $28.75 Feb 24, 2023 Direct
Rapport Therapeutics, Inc. Director Series B Preferred Stock 0 Jun 10, 2024 By Sofinnova Venture Partners XI, L.P.

Insider Reports Filed by James Healy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTRA Natera, Inc. Jul 26, 2024 1 $0 4 Jul 30, 2024 Director
RAPP Rapport Therapeutics, Inc. Jul 1, 2024 12 $1.08M 4 Jul 3, 2024 Director
NTRA Natera, Inc. Jun 28, 2024 1 $0 4 Jul 2, 2024 Director
BOLT Bolt Biotherapeutics, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 11, 2024 2 $0 4 Jun 13, 2024 Director
RAPP Rapport Therapeutics, Inc. Jun 10, 2024 7 $9.5M 4 Jun 10, 2024 Director
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 0 $0 3 Jun 6, 2024 Director
NTRA Natera, Inc. Apr 26, 2024 1 $0 4 Apr 30, 2024 Director
KRTX Karuna Therapeutics, Inc. Mar 18, 2024 9 -$473M 4 Mar 18, 2024 Director
AVBP ArriVent Biopharma, Inc. Jan 30, 2024 3 $8M 4 Jan 31, 2024 Director
NTRA Natera, Inc. Jan 26, 2024 1 $16.8K 4 Jan 30, 2024 Director
AVBP ArriVent Biopharma, Inc. Jan 25, 2024 0 $0 3 Jan 25, 2024 Director
NTRA Natera, Inc. Dec 13, 2023 1 -$37.8M 4 Dec 22, 2023 Director
NTRA Natera, Inc. Oct 27, 2023 1 $16.9K 4 Oct 31, 2023 Director
NTRA Natera, Inc. Jul 28, 2023 1 $15.9K 4 Aug 1, 2023 Director
NTRA Natera, Inc. Jun 30, 2023 2 $0 4 Jul 5, 2023 Director
KRTX Karuna Therapeutics, Inc. Jun 20, 2023 2 $0 4 Jun 22, 2023 Director
KRTX Karuna Therapeutics, Inc. Jun 14, 2023 2 $0 4 Jun 20, 2023 Director
BOLT Bolt Biotherapeutics, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 8, 2023 2 $0 4 Jun 9, 2023 Director
NTRA Natera, Inc. May 25, 2023 2 $0 4 May 30, 2023 Director
NTRA Natera, Inc. Apr 14, 2023 1 $15.6K 4 Apr 18, 2023 Director
NTRA Natera, Inc. Jan 13, 2023 1 $15.6K 4 Jan 18, 2023 Director
KRTX Karuna Therapeutics, Inc. Jan 12, 2023 3 -$1.2M 4 Jan 17, 2023 Director
CINC CinCor Pharma, Inc. Nov 28, 2022 4 -$85.9K 4 Feb 27, 2023 Director, 10%+ Owner
NTRA Natera, Inc. Nov 16, 2022 1 -$90.5K 4 Jan 18, 2023 Director
NTRA Natera, Inc. Oct 14, 2022 1 $15.6K 4 Oct 18, 2022 Director
CINC CinCor Pharma, Inc. Aug 11, 2022 2 $15.2M 4 Aug 15, 2022 Director, 10%+ Owner
KRTX Karuna Therapeutics, Inc. Aug 5, 2022 2 $520K 4 Aug 8, 2022 Director
CINC CinCor Pharma, Inc. Aug 5, 2022 2 $400K 4 Aug 8, 2022 Director, 10%+ Owner
YMAB Y-mAbs Therapeutics, Inc. Jul 15, 2022 1 $0 4 Jul 19, 2022 Director
NTRA Natera, Inc. Jul 8, 2022 1 $0 4/A Sep 2, 2022 Director
KRTX Karuna Therapeutics, Inc. Jun 29, 2022 6 $14.7M 4 Jul 1, 2022 Director
KRTX Karuna Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
BOLT Bolt Biotherapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 10, 2022 Director
NTRA Natera, Inc. May 27, 2022 2 $0 4 Jun 1, 2022 Director
NTRA Natera, Inc. May 25, 2022 2 $0 4 May 27, 2022 Director
KRTX Karuna Therapeutics, Inc. Apr 1, 2022 1 $6.08K 4 Apr 14, 2022 Director
BOLT Bolt Biotherapeutics, Inc. Mar 24, 2022 1 $0 4 Mar 28, 2022 Director
CINC CinCor Pharma, Inc. Jan 11, 2022 4 $5.2M 4 Jan 13, 2022 Director, 10%+ Owner
CHRS Coherus BioSciences, Inc. Jan 7, 2022 1 $0 4/A Feb 11, 2022 Director
CINC CinCor Pharma, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 Director, 10%+ Owner
CHRS Coherus BioSciences, Inc. Sep 27, 2021 3 -$7.25M 4 Sep 29, 2021 Director
NTRA Natera, Inc. Jul 22, 2021 1 $271K 4 Jul 26, 2021 Director
KRTX Karuna Therapeutics, Inc. Jul 2, 2021 1 $74.9K 4 Jul 7, 2021 Director
KRTX Karuna Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 23, 2021 Director
NTRA Natera, Inc. May 28, 2021 4 $0 4 Jun 2, 2021 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 10, 2020 1 $0 4 Jun 14, 2021 Director